Clinical trial
Exploring the Utility of a Novel Adaptive Device for Commercially Available Insulin Pens in Patients With Arthritis or Hand Deformities
NCT02779816 is registered in ClinicalTrials.gov with Levenson, David I., M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring the Utility of a Novel Adaptive Device for Commercially Available Insulin Pens in Patients With Arthritis or Hand Deformities
- Lead sponsor
- Levenson, David I., M.D.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 1, 2017
- Completion date
- July 2, 2018
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.